Staff Training Visits On Combination Products, Biocompatibility Sought By US FDA
This article was originally published in SRA
The US Food and Drug Administration wants to send staff to medical device manufacturing and healthcare facilities that specialize in one of eight focus areas in the latest iteration of a training program designed to give agency officials exposure to real-world challenges that device firms and other stakeholders face1.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.